Skip to main content
Future Journal of Pharmaceutical Sciences

Table 7 Result for change in mobile phase composition (± 2)

From: Analytical method development and validation for simultaneous estimation of Fimasartan Potassium Trihydrate and Cilnidipine in synthetic mixture by HPLC for the treatment of hypertension stage-II

Mobile phase composition

FIK

CLN

Mean are a ± SD

RSD

Mean area ± SD

RSD

58:05:37

6,325,438 ± 4312.18

0.06

1,050,499 ± 1351.24

0.12

60:05:35

6,326,703 ± 4516.74

0.07

1,050,768 ± 1893.69

0.18

62:05:33

6,325,294 ± 5268.55

0.08

1,049,372 ± 1721.31

0.16

Back to article page